Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 167,171 | 222,900 | 228,343 | 89,162 | 38,092 |
| Marketable Securities | 133,506 | 336,892 | 357,251 | 199,685 | 9,700 |
| Receivables | 73,540 | 54,298 | 16,976 | 14,670 | 5,860 |
| Inventories | 78,662 | 73,162 | 32,445 | 25,075 | 10,898 |
| Other current assets | 14,848 | 50,444 | 9,282 | 5,632 | 4,391 |
| TOTAL | $467,727 | $737,696 | $644,297 | $334,224 | $68,941 |
| Non-Current Assets | |||||
| PPE Net | 199,141 | 124,979 | 76,818 | 55,466 | 37,321 |
| Investments And Advances | 170,290 | 2,548 | 44,881 | 31,457 | 31,983 |
| Intangibles | 64,699 | 28,888 | 30,858 | 32,917 | 36,568 |
| Other Non-Current Assets | 15,306 | 12,584 | 18,425 | 9,372 | 20,490 |
| TOTAL | $449,436 | $168,999 | $170,982 | $129,212 | $126,362 |
| Total Assets | $917,163 | $906,695 | $815,279 | $463,436 | $195,303 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 70,741 | 6,309 | 6,787 | 11,337 |
| Accounts payable and accrued liabilities | 78,068 | 59,033 | 49,907 | 32,166 | 20,934 |
| TOTAL | $78,154 | $130,081 | $61,543 | $46,045 | $40,367 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 66,553 | 68,548 | 87,922 |
| Deferred Revenues | 86 | 307 | 5,327 | 7,092 | 8,096 |
| Other Non-Current Liabilities | 516,824 | 499,939 | 499,457 | 226,018 | 132,651 |
| TOTAL | $516,824 | $499,939 | $566,010 | $299,589 | $232,398 |
| Total Liabilities | $594,978 | $630,020 | $627,553 | $345,634 | $272,765 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,131 | 99,946 | 97,381 | 95,543 | 74,642 |
| Common Shares | 101 | 100 | 97 | 92 | 75 |
| Retained earnings | -577,084 | -576,596 | -607,427 | -591,624 | -563,091 |
| Other shareholders' equity | -782 | 224 | 139 | -25 | -16 |
| TOTAL | $322,185 | $276,675 | $187,726 | $117,802 | $-77,462 |
| Total Liabilities And Equity | $917,163 | $906,695 | $815,279 | $463,436 | $195,303 |